摘要
目的探索体外过表达Hint1基因对人肝肿瘤HepG2细胞AP-1转录因子活性的影响。方法分子克隆获得Hint1基因序列,构建pHA—Hint1重组融合基因表达载体。阳离子脂质体介导,pHA—Hint1转导人肝母细胞瘤HepG2细胞,RT—PCR和Western blot检测HepG2细胞中外源HA—Hintl表达。pHA—Hint1质粒、启动子荧光素酶报告质粒AP-1/Luc及巨细胞病毒-β-半乳糖酶报告质粒(β—gel)共转导HepG2细胞。36h后测定荧光素酶活性及β—gel活性。结果重组质粒经EcoR I和BamH I双酶切,获约100bp特异条带,测序证实成功构建pHA—Hint1表达载体。pHA—Hint1及空载体pcDNA3/HA转导HepG2细胞,半定量RT-PCR结果显示pHA—Hint1组Hint1 mRNA表达高于空载体组(t=3.89,P〈0.05);Western blot结果显示pHA-Hint1组HA标签蛋白表达高于空载体组(t=3.12,P〈0.05)。AP-1转录因子活性检测结果:pHA—Hint1终浓度为0μg/ml,0.5μg/ml,1.0μg/ml,1.5μg/ml,2.0μg/ml时,AP-1转录因子相对活性(10^6)为:5.12±0.25、4.24±0.74、3.43±0.31、2.62±0.48、2.09±0.21。随着pHA—Hint1浓度增加,荧光素酶活性呈明显下降,当pHA—Hint1浓度达到1.5μg及2.0μg时,差异有统计学意义(F=72.009,P〈0.05)。结论过表达Hint1基因可抑制HepG2细胞AP-1转录因子活性。
Objective To study the inhibition of AP-1 transcription factor activity by Hintl gene over expression in HepG2 cell lines. Methods The Hintl gene was amplified, and then was inserted into the pcDNA3/HA eukaryotic expression plasmid. The constructed pHA-Hintl plasmid was confirmed by DNA sequencing. The pHA-Hintl was transfected into the HepG2 human hepatoma cells. Semi-quantitative RT-PCR and Western-blot were used to detecte the expression of HA-Hintl. The HepG2 cells were cotransfected with pHA-Hintl and pAP-1/Luc luciferase reporter. At 36 h after transfection, luciferase assay system was used to detect the AP-1 transcription factor activity. Results The constructed pHA-Hintl was confirmed by DNA sequencing, pHA-Hintl gcne transduction through lipofectine induced over-expression in HA-Hintl mRNA (t = 3.89, P 〈 0. 05 ) and HA-Hintl protein ( t = 3.12, P 〈 0. 05 ). Co-transfection of Hintl gene inhibits AP-1 luciferase activity. Cotransfection with increased concentration of a pHA-Hintl plasmid (0 μg/ml, 0. 5μg/ml, 1.0 μg/ml, 1.5μg/ml, 2. 0 μg/ml) produced a concentration-dependent inhibition of AP-1 transcription factor activity. At the concentration of 1.5 μg/ml, and 2. 0 μg/ml, the activity inhibition reaches significant difference ( F = 72. 009, P 〈 0. 05 ). Conclusion Over-expression of Hintl can, at least in part, inhibit the AP-1 transcription factor activity in HepG2 cells.
出处
《中华普通外科杂志》
CSCD
北大核心
2009年第8期663-666,共4页
Chinese Journal of General Surgery
基金
国家自然科学基金资助项目(30660184)
云南省自然科学基金资助项目(2006C0057Q)
云南省中青年学术技术带头人后备人才基金资助项目(2008PYD18)